Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of Bad.

作者: Raluca Rusovici , Amr Ghaleb , Hyunsuk Shim , Vincent W. Yang , C. Chris Yun

DOI: 10.1016/J.BBAGEN.2007.04.008

关键词: Lysophosphatidic acidMitogen-activated protein kinaseCell biologyPhosphorylationCaspase 3PI3K/AKT/mTOR pathwayCell signalingBiologyCancer researchMAPK/ERK pathwayCaspase 7

摘要: Lysophosphatidic acids (LPA) exert growth factor-like effects through specific G protein-coupled receptors. The presence of different LPA receptors often determines the signaling mechanisms and physiological consequences in environments. Among four members receptor family, LPA2 has been shown to be overexpressed colon cancer suggesting that by may potentiate survival tumor cells. In this study, we examined effect on cells using Caco-2 as a cell model system. rescued from apoptosis elicited chemotherapeutic drug, etoposide. This protection was accompanied abrogation etoposide-induced stimulation caspase activity via mechanism dependent Erk PI3K. contrast, perturbation cellular mediated knockdown scaffold protein NHERF2 abrogated protective LPA. Etoposide decreased expression Bcl-2, which reversed phosphorylation level proapoptotic Bad an Erk-dependent manner, without changing expression. We further show treatment resulted delayed activation Erk. These results indicate protects apoptotic insult involving Erk, Bad, Bcl-2.

参考文章(68)
Edward J. Goetzl, Yvonne Kong, Baisong Mei, Lysophosphatidic Acid and Sphingosine 1-Phosphate Protection of T Cells from Apoptosis in Association with Suppression of Bax Journal of Immunology. ,vol. 162, pp. 2049- 2056 ,(1999)
Julian Downward, How BAD phosphorylation is good for survival. Nature Cell Biology. ,vol. 1, ,(1999) , 10.1038/10026
Rémy Gauthier, Charlène Harnois, Jean-François Drolet, John C. Reed, Anne Vézina, Pierre H. Vachon, Human intestinal epithelial cell survival: differentiation state-specific control mechanisms American Journal of Physiology-cell Physiology. ,vol. 280, pp. 1540- 1554 ,(2001) , 10.1152/AJPCELL.2001.280.6.C1540
Y Xu, X J Fang, G Casey, G B Mills, Lysophospholipids activate ovarian and breast cancer cells Biochemical Journal. ,vol. 309, pp. 933- 940 ,(1995) , 10.1042/BJ3090933
Russell O. Pieper, Yuichi Hirose, Mitchel S. Berger, p53 Effects Both the Duration of G2/M Arrest and the Fate of Temozolomide-treated Human Glioblastoma Cells Cancer Research. ,vol. 61, pp. 1957- 1963 ,(2001)
G B Mills, C May, M Hill, S Campbell, P Shaw, A Marks, Ascitic Fluid from Human Ovarian Cancer Patients Contains Growth Factors Necessary for Intraperitoneal Growth of Human Ovarian Adenocarcinoma Cells Journal of Clinical Investigation. ,vol. 86, pp. 851- 855 ,(1990) , 10.1172/JCI114784
Daniela Trisciuoglio, Marianna Desideri, Ludovica Ciuffreda, Marcella Mottolese, Domenico Ribatti, Angelo Vacca, Mario Del Rosso, Lucia Marcocci, Gabriella Zupi, Donatella Del Bufalo, Bcl‐2 overexpression in melanoma cells increases tumor progression‐associated properties and in vivo tumor growth Journal of Cellular Physiology. ,vol. 205, pp. 414- 421 ,(2005) , 10.1002/JCP.20413
Qingming Ding, Qingding Wang, B.Mark Evers, Alterations of MAPK activities associated with intestinal cell differentiation. Biochemical and Biophysical Research Communications. ,vol. 284, pp. 282- 288 ,(2001) , 10.1006/BBRC.2001.4969
Z. Xia, M. Dickens, J. l Raingeaud, R. J. Davis, M. E. Greenberg, Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis Science. ,vol. 270, pp. 1326- 1331 ,(1995) , 10.1126/SCIENCE.270.5240.1326